Tufts Cancer Symposium

The Inaugural Tufts Cancer Symposium "Precision Medicine: New Paths to Cancer Therapies through Convergent Research" took place on October 27, 2016 and showcased top minds who are shaping the future of cancer research. The symposium was attended by over 200 members of the scientific community, medical professionals and Tufts community members. View photos from the symposium »

Information about the 2017 Tufts Cancer Symposium will be posted soon.

A leader in convergent research, Tufts University School of Medicine is bringing together top minds in cancer research and other scientific disciplines to foster a culture of cooperation and innovation among researchers across discipline boundaries, sharing their thinking and illuminating new paths to effective cancer therapies.

2016 Program:


The robust program consists of lectures and panel discussions that focus on concepts and applications of precision medicine and how multidisciplinary, convergent research can provide us with innovative approaches to expedite the discovery and implementation of new custom-tailored cancer therapies.

This year’s symposium will have two sessions with a keynote address each and lunch sessions. Please see the full details by clicking the links below:
8:00 AM - 9:00 AM  Breakfast & Registration
9:00 AM - 12:00 PM  Convergence Research Session
12:00 PM - 2:00 PM  Lunch Sessions
2:00 PM - 5:00 PM  Precision Medicine Session
5:00 PM - 6:30 PM  Wine and Cheese Reception

Read full program

Administration:


Co-Directors

Phil Hinds, Ph.D.
Professor and Chair, Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine

Charlotte Kuperwasser, Ph.D.
Professor of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine; Director, Raymond and Beverly Sackler Convergence Laboratory (RBSCL); Investigator, Molecular Oncology Research Institute (MORI), Tufts Medical Center

Karl Munger, Ph.D.
Professor of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine

Larry Steranka, Ph.D.
Senior Director, Office for Technology Transfer and Industry Collaboration, Tufts University

Amy Yee, Ph.D.
Professor of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine; President, American Association of Cancer Research (AACR) Boston, Inc.

Staff and University Leadership

Harris A. Berman, M.D., F.A.C.P.
Dean, Tufts University School of Medicine

Naomi Rosenberg, Ph.D.
Dean, Sackler School of Graduate Biomedical Sciences, Tufts University

Ippolita Cantuti-Castelvetri, Ph.D.
Senior Director of Corporate and Foundation Relations, Tufts University

2016 Session Descriptions:


Convergence Research Session
Location: Behrakis Auditorium, 1st Floor, Jaharis Building, 150 Harrison Avenue
Session Moderator: Phil Hinds, Ph.D., Professor and Chair, Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine

  • 9:10-10:00 AM Keynote Lecture "Convergence to Overcome Cancer: Strategies and Mechanisms to Prevent Disease"
    Charlotte Kuperwasser, Ph.D., Professor of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine; Director, Raymond and Beverly Sackler Convergence Laboratory; Investigator, Molecular Oncology Research Institute, Tufts Medical Center
    Watch this presentation on YouTube

  • 10:00-10:30 AM "Tissue Engineering Strategies to Study Cancer"
    David Kaplan, Ph.D., Stern Family Professor of Engineering; Professor and Chair, Department of Biomedical Engineering, Tufts University School of Engineering
    Watch this presentation on YouTube

  • 11:00-11:30 AM "Different Targets Require Different Molecules: Chemical Approaches to Unlocking New Cancer Therapies"
    Joshua Kritzer, Ph.D., Associate Professor of Chemistry, Department of Chemistry, Tufts University School of Arts and Sciences
    Watch this presentation on YouTube

  • 11:30 AM-12:00 PM "From the Identification of Cancer Vulnerabilities to Therapeutic Development"
    William R. Sellers, M.D., Former Vice President and Global Head of Oncology, Novartis Institutes for BioMedical Research
    Watch this presentation on YouTube

▲ Back to Program

12:00-2:00 PM Lunch

Option 1: Networking Lunch. W Hotel Great Room, 100 Stuart Street, Boston

Option 2: Lunch Panel, "The Future of Cancer Research: Opportunities and Priorities," moderated by Robert Tepper, M.D., Partner and Co-Founder, Third Rock Ventures. Sackler Center, Room 114, 145 Harrison Avenue

Luncheon panelists: Clive Stanway, Ph.D., Chief Scientific Officer of Cancer Research Technology (CRT); Barbara Spalholz, Ph.D., Chief, Cancer Cell Biology Branch, Division of Cancer Biology, National Cancer Institute; Leah Cann, Founder of Hope for Cancer Research Foundation; William Phelps, Ph.D., Vice President for Extramural Research, American Cancer Society; William R. Sellers, M.D., Former Vice President and Global Head of Oncology, Novartis Institutes for BioMedical Research; and Robert Tepper, M.D., Partner and Co-Founder, Third Rock Ventures, who will moderate.
Watch this panel discussion on YouTube.

▲ Back to Program

Precision Medicine Session
Location: Behrakis Auditorium, 1st Floor, Jaharis Building, 150 Harrison Avenue
Session Moderator: Andrew Evens, D.O., M.Sc., F.A.C.P., Director, Tufts Cancer Center; Chan Soon-Shiong Endowed Scholar in Precision Medicine; Professor and Chief, Division of Hematology/ Oncology; Professor of Medicine, Tufts University School of Medicine

  • 2:00-2:30 PM "Wnt Signaling and Green Tea: A Tale of Breast and Brain"
    Amy Yee, Ph.D., Professor of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine; President, American Association of Cancer Research (AACR) Boston, Inc.
    Watch this presentation on YouTube

  • 2:30-3:00 PM "ADAM8: a Novel Target for Treatment of Triple-Negative Breast Cancer"
    Gail Sonenshein, Ph.D., Professor of Developmental, Molecular and Chemical Biology, Sackler School of Graduate Biomedical Sciences, Tufts University
    Watch this presentation on YouTube

  • 3:00-3:30 PM "Future Paradigms for Precision Oncology"
    Giannoula Lakka Klement, M.D., Co-Director, Personalized Cancer Care Program, Tufts Medical Center; Chief, Academic and Research Affairs, Division of Pediatric Hematology/Oncology; Director, Rare Tumors and Vascular Anomalies Program; Pediatric Hematologist/Oncologist; Assistant Professor, Tufts University School of Medicine
    Watch this presentation on YouTube

  • 3:50-4:00 PM Introduction of Keynote Lecture
    Amy Yee, Ph.D., Professor of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine; President, American Association of Cancer Research (AACR) Boston, Inc.

  • 4:00-4:50 PM AACR-Boston Ruth Sager Memorial Keynote Lecture "How Aneuploidy Drives Cancer"
    Stephen J. Elledge, Ph.D., Gregor Mendel Professor of Genetics and Medicine, Department of Genetics, Harvard Medical School; Division of Genetics, Brigham and Women’s Hospital; Investigator, Howard Hughes Medical Institute
    Watch this presentation on YouTube.

  • 4:50 to 5:00 PM Closing Remarks
    Harris A. Berman, M.D., F.A.C.P., Dean, Tufts University School of Medicine

  • 5:00-6:30 PM Wine and Cheese Reception
    Dental Alumni Lounge, 15th Floor, 1 Kneeland Street

▲ Back to Program

Queries?


Please contact Emily Schipper at the Office of Special Events, emily.schipper@tufts.edu, 617-627-4969.

2016 Sponsors:

 


 

Hotel Information:


We will have a negotiated hotel rate for the 2017 Tufts Cancer Symposium. Information will be posted soon.